VLY-686
VP-VLY-686-1101
Phase 1 small_molecule completed
Quick answer
VLY-686 for Pruritus is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Pruritus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed